Suppr超能文献

黄芪甲苷对脑缺血再灌注损伤保护作用的研究进展

Research Progress on the Ability of Astragaloside IV to Protect the Brain Against Ischemia-Reperfusion Injury.

作者信息

Kang Xianhui, Su Shuyue, Hong Wandong, Geng Wujun, Tang Hongli

机构信息

Department of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Department of Anesthesiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Front Neurosci. 2021 Nov 16;15:755902. doi: 10.3389/fnins.2021.755902. eCollection 2021.

Abstract

Stroke, a disease with a sudden onset and high morbidity and mortality rates, is difficult to treat in the clinic. Traditional Chinese medicine has become increasingly widely used in clinical practice. Modern pharmacological studies have found that Radix Astragali has a variety of medicinal properties, i.e., immunoregulatory, antioxidative, anti-cancer, anti-diabetes, myocardial protective, hepatoprotective, and antiviral functions. This article reviews the protective effect and mechanism of astragaloside IV, which is extracted from Radix Astragali, on stroke, discusses the cerebroprotective effect of astragaloside IV against ischemia-reperfusion-related complications, offers insight into research prospects, and expands the idea of integrating traditional Chinese and Western medicine treatment strategies and drugs to provide a theoretical reference for the clinical treatment of cerebral ischemia-reperfusion injury and the improvement of stroke prognosis.

摘要

中风是一种起病急、发病率和死亡率高的疾病,临床治疗困难。中药在临床实践中的应用越来越广泛。现代药理学研究发现,黄芪具有多种药理特性,即免疫调节、抗氧化、抗癌、抗糖尿病、心肌保护、肝脏保护和抗病毒功能。本文综述了从黄芪中提取的黄芪甲苷对中风的保护作用及机制,探讨了黄芪甲苷对缺血再灌注相关并发症的脑保护作用,展望了研究前景,拓展了中西医结合治疗策略和药物的思路,为脑缺血再灌注损伤的临床治疗及改善中风预后提供理论参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3797/8637115/207271d6be5b/fnins-15-755902-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验